Ads
related to: vertex pharmaceuticals news
Search results
Is This Vertex Pharmaceuticals' Biggest News Yet?
Motley Fool· 2 years agoIt's been a big year for Vertex Pharmaceuticals (NASDAQ: VRTX) so far. The biotech company has grown its main cystic fibrosis (CF) business -- reporting...
Vertex Pharmaceuticals: Buy at the High?
Motley Fool· 2 years agoVertex Pharmaceuticals (NASDAQ: VRTX) has a lot going on these days. The biotech company is developing two candidates that could make it even stronger in...
Vertex Pharmaceuticals Just Proved Something Big to Investors. Time to Buy?
Motley Fool· 5 months agoVertex Pharmaceuticals (NASDAQ: VRTX) has built a billion-dollar cystic fibrosis (CF) treatment...
Vertex Pharmaceuticals Stock Is Approaching a Huge Catalyst, But Is It a Buy?
Motley Fool via Yahoo Finance· 3 months agoVertex Pharmaceuticals (NASDAQ: VRTX) shareholders know just how good it can be to ride a biopharma...
2 Green Flags for Vertex Pharmaceuticals' Future
Motley Fool· 2 years agoBiotech Vertex Pharmaceuticals (NASDAQ: VRTX) is defying the stock market sell-off this year. While that's great news for shareholders, it's essential to...
This Growth Stock Crushed the Market Last Year. 5 Words from the CEO Suggest There's More to Come.
Motley Fool· 1 year agoVertex Pharmaceuticals (NASDAQ: VRTX) stock climbed more than 31% last year even as the overall...
Why Vertex Stock Is Soaring Today
Motley Fool via Yahoo Finance· 5 months agoShares of Vertex Pharmaceuticals (NASDAQ: VRTX) are up by more than 11% headed into the latter half of Wednesday's trading session, catapulted higher by...
Vertex Pharmaceuticals Stock Sees Rising Relative Strength
Investor's Business Daily· 1 year agoVertex Pharmaceuticals stock saw a positive improvement to its Relative Strength (RS) Rating on...
Vertex Pharmaceuticals Will Use $100 Million to Tank Its Own Market Share. Here's Why That's a Smart...
Motley Fool via Yahoo Finance· 3 months agoHot off the approval of its gene therapy for a pair of rare hereditary blood disorders, Vertex...
Alpine Catapults 37% After Vertex Pledges $4.9 Billion To Buy It
Investor's Business Daily· 1 month agoAnalysts applauded Vertex Pharmaceuticals on Thursday for its acquisition of Alpine Immune Sciences...
Ad
related to: vertex pharmaceuticals news
